Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Pulmonary Hypertension Drugs Price Analysis and Strategies - 2016 - Research and Markets

Research and Markets
Posted on: 03 Nov 16

Research and Markets has announced the addition of the "Pulmonary Hypertension Drugs Price Analysis and Strategies - 2016" report to their offering.

The latest research Pulmonary Hypertension Drugs Price Analysis and Strategies - 2016, provides drug pricing data and benchmarks in the global Pulmonary Hypertension market.

The research answers the following questions:

  • What are the key drugs marketed for Pulmonary Hypertension and their clinical attributes?
  • How are they positioned in the Global Pulmonary Hypertension market?
  • What are the unit prices and annual treatment cost for Pulmonary Hypertension therapies in different countries?
  • What are the drug pricing trends and how are they expected to change in the future?
  • How are the drug pricing and reimbursement landscape different by countries?
  • What are the unmet needs in the global Pulmonary Hypertension drugs market?
  • What would be the ideal pricing strategy for a new pipeline therapy for Pulmonary Hypertension?

Research Scope:

Pulmonary Hypertension Treatment Options - Identify key drugs marketed and prescribed for Pulmonary Hypertension in the US, Germany, France, Italy, Spain, UK, Japan including trade name, molecule name, and company

Pulmonary Hypertension Drugs Attributes - Find out the safety, efficacy, and risk benefit for key drugs marketed for Pulmonary Hypertension

Market Positioning - Identify how drugs are clinically and commercially positioned in the global Pulmonary Hypertension market

Pulmonary Hypertension Drugs Price Analysis - Find out the annual therapy cost and unit price for key drugs marketed for Pulmonary Hypertension in the US, Germany, France, Italy, Spain, UK, Japan. Find out how the price advanced from 2012 and forecast to 2021

Pricing & Reimbursement Landscape - Find out the pricing and reimbursement landscape in the US, Germany, France, Italy, Spain, UK, Japan

Pulmonary Hypertension New Drug Pricing - Identify the effective pricing strategy for a new drug launch in the US, Germany, France, Italy, Spain, UK, Japan

This research will help executives

  • Identify clinical attributes of your competitor drugs
  • Find out how the marketed products for Pulmonary Hypertension are clinically and commercially positioned
  • Understand the price of your competitor drugs by countries
  • Use Pulmonary Hypertension drugs price data for market sizing, drug sales forecast, budgeting, competitive intelligence, HEOR, and reimbursement
  • Find out the pricing and reimbursement landscape by countries
  • Identify the unmet need in global Pulmonary Hypertension market
  • Identify the effective pricing for a new drug

For more information about this report visit http://www.researchandmarkets.com/research/2bx3pc/pulmonary

View source version on businesswire.com: http://www.businesswire.com/news/home/20161103005779/en/

Business Wire
www.businesswire.com

Last updated on: 03/11/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.